Arcellx (ACLX) Common Equity (2021 - 2025)

Arcellx's (ACLX) quarterly Common Equity came in at $402.4 million in Q4 2025, down 11.53% year-on-year from $454.8 million in Q4 2024, and down 8.72% quarter-over-quarter from $440.8 million in Q3 2025.

Arcellx (ACLX) Common Equity (2021 - 2025) Analysis & Trends

Arcellx's Common Equity history runs 5 years deep, the most recent figure standing at $402.4 million for Q4 2025.

  • On a quarterly basis, Common Equity fell 11.53% year-over-year to $402.4 million in Q4 2025; TTM through Dec 2025 was $402.4 million, a 11.53% decrease from a year earlier, with the FY2025 full-year figure at $402.4 million, down 11.53% from the prior year.
  • Common Equity retreated to $402.4 million in Q4 2025 per ACLX's latest filing, from $440.8 million in the prior quarter.
  • Across five years, Common Equity topped out at $496.6 million in Q1 2024 and bottomed at -$205.0 million in Q4 2022.
  • The 5-year median for Common Equity is $313.7 million (2022), against an average of $255.9 million.
  • Biggest YoY gain for Common Equity was 464.65% in 2022; the steepest drop was 68.67% in 2022.
  • Year by year, Common Equity stood at -$121.5 million in 2021, then tumbled by 68.67% to -$205.0 million in 2022, then soared by 336.82% to $485.4 million in 2023, then declined by 6.3% to $454.8 million in 2024, then dropped by 11.53% to $402.4 million in 2025.
  • Per Business Quant, the three latest ACLX Common Equity figures stand at $402.4 million (Q4 2025), $440.8 million (Q3 2025), and $392.2 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Arcellx 6.48 Bn 6.48 Bn - 402.35 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 402.35 Mn
Sep 30, 2025 440.78 Mn
Jun 30, 2025 392.22 Mn
Mar 31, 2025 416.91 Mn
Dec 31, 2024 454.79 Mn
Sep 30, 2024 483.02 Mn
Jun 30, 2024 487.16 Mn
Mar 31, 2024 496.57 Mn
Dec 31, 2023 485.38 Mn
Sep 30, 2023 266.13 Mn
Jun 30, 2023 293.67 Mn
Mar 31, 2023 303.72 Mn
Dec 31, 2022 -204.95 Mn
Sep 30, 2022 236.28 Mn
Jun 30, 2022 323.62 Mn
Mar 31, 2022 227.94 Mn
Dec 31, 2021 -121.52 Mn
Sep 30, 2021 -103.80 Mn
Jun 30, 2021 -88.75 Mn
Mar 31, 2021 -74.23 Mn